Childhood systemic lupus erythematosus, dermatomyositis, scleroderma, and systemic vasculitis.
Recent developments in the identification of prognostic features, measures of disease activity, and responses to therapy in the childhood rheumatic diseases are summarized. Progress in understanding the immunopathogenesis of neonatal lupus erythematosus phenomenon and Kawasaki disease is reviewed.